Trial Profile
A Phase 2, Open-label, Pharmacokinetic Study of a Single Intra-articular Administration of TLC599 in Subjects With Mild to Moderate Osteoarthritis of the Knee
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2024
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Osteoarthritis
- Focus Pharmacokinetics; Registrational
- Sponsors Taiwan Liposome Company
- 05 Jan 2024 Status changed from recruiting to completed.
- 05 Oct 2023 Planned number of patients changed from 90 to 102.
- 05 Oct 2023 Planned End Date changed from 30 Jun 2022 to 30 Nov 2023.